{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:47:45Z","timestamp":1792640865011,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s11926-019-0864-3","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T07:02:51Z","timestamp":1574319771000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["PET Scan: Nuclear Medicine Imaging in Myositis"],"prefix":"10.1007","volume":"21","author":[{"given":"Albert","family":"Selva-O\u2019Callaghan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Gil-Vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Sim\u00f3-Perdig\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Trallero-Aragu\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Alvarado-C\u00e1rdenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iago","family":"Pinal-Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,21]]},"reference":[{"key":"864_CR1","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJMra1402225","volume":"372","author":"MC Dalakas","year":"2015","unstructured":"Dalakas MC. Inflammatory muscle diseases. N Engl J Med. 2015;372:1734\u201347.","journal-title":"N Engl J Med"},{"key":"864_CR2","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S1474-4422(18)30254-0","volume":"17","author":"A Selva-O\u2019Callaghan","year":"2018","unstructured":"Selva-O\u2019Callaghan A, Pinal-Fernandez I, Trallero-Aragu\u00e1s E, Milisenda JC, Grau-Junyent JM, Mammen AL. Classification and management of adult inflammatory myopathies. Lancet Neurol. 2018;17:816\u201328.","journal-title":"Lancet Neurol"},{"key":"864_CR3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/1203475416665601","volume":"21","author":"JK Qiang","year":"2017","unstructured":"Qiang JK, Kim WB, Baibergenova A, Alhusayen R. Risk of malignancy in dermatomyositis and polymyositis. J Cutan Med Surg. 2017;21:131\u20136.","journal-title":"J Cutan Med Surg"},{"key":"864_CR4","doi-asserted-by":"crossref","first-page":"17N","DOI":"10.2967\/jnumed.108.050401","volume":"49","author":"S Basu","year":"2008","unstructured":"Basu S, Alavi A. Unparalleled contribution of 18F-FDG PET to medicine over 3 decades. J Nucl Med. 2008;49:17N\u201321N 37N.","journal-title":"J Nucl Med"},{"key":"864_CR5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.semnuclmed.2008.10.006","volume":"39","author":"S Basu","year":"2009","unstructured":"Basu S, Zhuang H, Torigian DA, Rosenbaum J, Chen W, Alavi A. Functional imaging of inflammatory diseases using nuclear medicine techniques. Semin Nucl Med. 2009;39:124\u201345.","journal-title":"Semin Nucl Med"},{"key":"864_CR6","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","volume":"42","author":"R Boellaard","year":"2015","unstructured":"Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, et al. European Association of Nuclear Medicine (EANM). FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328\u201354.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"864_CR7","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.7326\/0003-4819-134-12-200106190-00008","volume":"134","author":"R Buchbinder","year":"2001","unstructured":"Buchbinder R, Forbes A, Hall S, Dennett X, Giles G. Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study. Ann Intern Med. 2001;134:1087\u201395.","journal-title":"Ann Intern Med"},{"key":"864_CR8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJM199202063260602","volume":"326","author":"B Sigurgeirsson","year":"1992","unstructured":"Sigurgeirsson B, Lindelof B, Edhag O, Allander E. Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med. 1992;326:363\u20137.","journal-title":"N Engl J Med"},{"key":"864_CR9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","volume":"357","author":"CL Hill","year":"2001","unstructured":"Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet. 2001;357:96\u2013100.","journal-title":"Lancet"},{"key":"864_CR10","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/brain\/aww054","volume":"139","author":"Y Allenbach","year":"2016","unstructured":"Allenbach Y, Keraen J, Bouvier AM, Jooste V, Champtiaux N, Hervier B, et al. High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody. Brain. 2016;139:2131\u20135.","journal-title":"Brain."},{"key":"864_CR11","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/art.33379","volume":"64","author":"E Trallero-Aragu\u00e1s","year":"2012","unstructured":"Trallero-Aragu\u00e1s E, Rodrigo-Pend\u00e1s JA, Selva-O\u2019Callaghan A, et al. Usefulness of antip155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis. Arthritis Rheum. 2012;64:523\u201332.","journal-title":"Arthritis Rheum"},{"key":"864_CR12","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1002\/acr.23188","volume":"69","author":"J Albayda","year":"2017","unstructured":"Albayda J, Pinal-Fernandez I, Huang W, Parks C, Paik J, Casciola-Rosen L, et al. Antinuclear matrix protein 2 autoantibodies and edema, muscle disease, and malignancy risk in dermatomyositis patients. Arthritis Care Res (Hoboken). 2017;69:1771\u20136.","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"864_CR13","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.amjmed.2009.11.012","volume":"123","author":"A Selva-O\u2019Callaghan","year":"2010","unstructured":"Selva-O\u2019Callaghan A, Grau JM, G\u00e1mez-Cenzano C, Vidaller-Palac\u00edn A, Mart\u00ednez-G\u00f3mez X, Trallero-Aragu\u00e1s E, et al. Conventional cancer screening versus PET\/CT in dermatomyositis\/polymyositis. Am J Med. 2010;123:558\u201362.","journal-title":"Am J Med"},{"key":"864_CR14","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.semarthrit.2018.10.021","volume":"49","author":"A Kundrick","year":"2018","unstructured":"\u2022 Kundrick A, Kirby J, Ba D, Leslie D, Olsen N, Foulke G. Positron emission tomography costs less to patients than conventional screening for malignancy in dermatomyositis. Semin Arthritis Rheum. 2018;49:140\u20134. https:\/\/doi.org\/10.1016\/j.semarthrit.2018.10.021. This study states that PET\/CT whole body may be expensive for insurance companies but not for the patients, opening the door to more generalised implementation of PET\/CT for dermatomyositis cancer screening in countries where this test is not available through publically-funded health resources.","journal-title":"Semin Arthritis Rheum"},{"key":"864_CR15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/MNM.0000000000000981","volume":"40","author":"PG Maliha","year":"2019","unstructured":"Maliha PG, Hudson M, Abikhzer G, Singerman J, Probst S. 18F-FDG PET\/CT versus conventional investigations for cancer screening in autoimmune inflammatory myopathy in the era of novel myopathy classifications. Nucl Med Commun. 2019;40:377\u201382.","journal-title":"Nucl Med Commun"},{"key":"864_CR16","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/BOR.0000000000000535","volume":"30","author":"A Selva-O\u2019Callaghan","year":"2018","unstructured":"Selva-O\u2019Callaghan A, Mart\u00ednez-G\u00f3mez X, Trallero-Aragu\u00e1s E, Pinal-Fern\u00e1ndez I. The diagnostic work-up of cancer-associated myositis. Curr Opin Rheumatol. 2018;30:630\u20136.","journal-title":"Curr Opin Rheumatol"},{"issue":"Suppl 11","key":"864_CR17","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1002\/acr.20532","volume":"63","author":"LG Rider","year":"2011","unstructured":"Rider LG, Werth VP, Huber AM, Alexanderson H, Rao AP, Ruperto N, et al. Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient\/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)\/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI). Arthritis Care Res (Hoboken). 2011;63(Suppl 11):S118\u201357.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"864_CR18","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/annrheumdis-2016-210198","volume":"76","author":"I Pinal-Fernandez","year":"2017","unstructured":"Pinal-Fernandez I, Casal-Dominguez M, Carrino JA, Lahouti AH, Basharat P, Albayda J, et al. Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity. Ann Rheum Dis. 2017;76:681\u20137.","journal-title":"Ann Rheum Dis"},{"key":"864_CR19","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006763","volume":"5","author":"M Tateyama","year":"2015","unstructured":"Tateyama M, Fujihara K, Misu T, Arai A, Kaneta T, Aoki M. Clinical values of FDG PET in polymyositis and dermatomyositis syndromes: imaging of skeletal muscle inflammation. BMJ Open. 2015;5:e006763.","journal-title":"BMJ Open"},{"key":"864_CR20","first-page":"570","volume":"30","author":"N Pipitone","year":"2012","unstructured":"Pipitone N, Versari A, Zuccoli G, Levrini G, Macchioni P, Bajocchi G, et al. 18F-Fluorodeoxyglucose positron emission tomography for the assessment of myositis: a case series. Clin Exp Rheumatol. 2012;30:570\u20133.","journal-title":"Clin Exp Rheumatol"},{"key":"864_CR21","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.3899\/jrheum.111597","volume":"39","author":"T Owada","year":"2012","unstructured":"Owada T, Maezawa R, Kurasawa K, Okada H, Arai S, Fukuda T. Detection of inflammatory lesions by F-18 fluorodeoxyglucose positron emission tomography in patients with polymyositis and dermatomyositis. J Rheumatol. 2012;39:1659\u201365.","journal-title":"J Rheumatol"},{"key":"864_CR22","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00259-004-1757-9","volume":"32","author":"MA Walter","year":"2005","unstructured":"Walter MA, Melzer RA, Schindler C, Muller-Brand J, Tyndall A, Nitzsche EU. The value of [18F] FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging. 2005;32:674\u201381.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"864_CR23","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/rheumatology\/ket112","volume":"52","author":"S Tanaka","year":"2013","unstructured":"Tanaka S, Ikeda K, Uchiyama K, Iwamoto T, Sanayama Y, Okubo A, et al. [18F] FDG uptake in proximal muscles assessed by PET\/CT reflects both global and local muscular inflammation and provides useful information in the management of patients with polymyositis\/dermatomyositis. Rheumatology (Oxford). 2013;52:1271\u20138.","journal-title":"Rheumatology (Oxford)"},{"key":"864_CR24","first-page":"5023","volume":"15","author":"L Sun","year":"2018","unstructured":"Sun L, Dong Y, Zhang N, Lv X, Chen Q, Wei W. [(18)F] Fluorodeoxyglucose positron emission tomography\/computed tomography for diagnosing polymyositis\/dermatomyositis. Exp Ther Med. 2018;15:5023\u20138.","journal-title":"Exp Ther Med"},{"key":"864_CR25","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/mus.24307","volume":"51","author":"J Van De Vlekkert","year":"2015","unstructured":"Van De Vlekkert J, Maas M, Hoogendijk JE, De Visser M, Van Schaik IN. Combining MRI and muscle biopsy improves diagnostic accuracy in subacute-onset idiopathic inflammatory myopathy. Muscle Nerve. 2015;51:253\u20138.","journal-title":"Muscle Nerve"},{"issue":"8","key":"864_CR26","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1093\/rheumatology\/kez040","volume":"58","author":"Julien Matuszak","year":"2019","unstructured":"\u2022\u2022 Matuszak J, Blondet C, Hubel\u00e9 F, Gottenberg JE, Sibilia J, Bund C, et al. Muscle fluorodeoxyglucose uptake assessed by positron emission tomography-computed tomography as a biomarker of inflammatory myopathies disease activityRheumatology (Oxford). 2019. https:\/\/doi.org\/10.1093\/rheumatology\/kez040 This is a well conducted study which demonstrates that PET\/CT could be useful for monitoring muscle disease activity. The method that they used to measure muscle activity showed an excellent reliability and validity.","journal-title":"Rheumatology"},{"key":"864_CR27","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/acr.21728","volume":"64","author":"H Cao","year":"2012","unstructured":"Cao H, Pan M, Kang Y, Xia Q, Li X, Zhao X, et al. Clinical manifestations of dermatomyositis and clinically amyopathic dermatomyositis patients with positive expression of anti-melanoma differentiation-associated gene 5 antibody. Arthritis Care Res (Hoboken). 2012;64:1602\u201310.","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"864_CR28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.semarthrit.2016.03.011","volume":"46","author":"E Trallero-Aragu\u00e1s","year":"2016","unstructured":"Trallero-Aragu\u00e1s E, Grau-Junyent JM, Labirua-Iturburu A, Garc\u00eda-Hern\u00e1ndez FJ, Monteagudo-Jim\u00e9nez M, Fraile-Rodriguez G, et al. Clinical manifestations and long-term outcome of anti-Jo1 antisynthetase patients in a large cohort of Spanish patients from the GEAS-IIM group. Semin Arthritis Rheum. 2016;46:225\u201331.","journal-title":"Semin Arthritis Rheum"},{"key":"864_CR29","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1055\/s-0039-1685187","volume":"40","author":"T Barba","year":"2019","unstructured":"Barba T, Mainbourg S, Nasser M, Lega JC, Cottin V. Lung diseases in inflammatory myopathies. Semin Respir Crit Care Med. 2019;40:255\u201370.","journal-title":"Semin Respir Crit Care Med"},{"key":"864_CR30","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/1346-8138.14758","volume":"46","author":"SI Motegi","year":"2019","unstructured":"Motegi SI, Fujiwara C, Sekiguchi A, Hara K, Yamaguchi K, Maeno T, et al. Clinical value of (18) F-fluorodeoxyglucose positron emission tomography\/computed tomography for interstitial lung disease and myositis in patients with dermatomyositis. J Dermatol. 2019;46:213\u20138.","journal-title":"J Dermatol"},{"key":"864_CR31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/14397595.2015.1054099","volume":"26","author":"T Uehara","year":"2016","unstructured":"Uehara T, Takeno M, Hama M, Yoshimi R, Suda A, Ihata A, et al. Deep-inspiration breath-hold 18F-FDG-PET\/CT is useful for assessment of connective tissue disease associated interstitial pneumonia. Mod Rheumatol. 2016;26:121\u20137.","journal-title":"Mod Rheumatol"},{"key":"864_CR32","first-page":"22","volume":"48","author":"SA Nehmeh","year":"2007","unstructured":"Nehmeh SA, Ertii YE, Meirelles GS, Squire O, Larson SM, Humm JL, et al. Deep-inspiration breath-hold PET\/CT of the thorax. J Nucl Med. 2007;48:22\u20136.","journal-title":"J Nucl Med"},{"key":"864_CR33","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.2169\/internalmedicine.51.6813","volume":"51","author":"Y Morita","year":"2012","unstructured":"Morita Y, Kuwagata S, Kato N, Tsujimura Y, Mizutani H, Suehiro M, et al. 18F-FDG PET\/CT useful for the early detection of rapidly progressive fatal interstitial lung disease in dermatomyositis. Intern Med. 2012;51:1613\u20138.","journal-title":"Intern Med"},{"key":"864_CR34","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1007\/s10067-017-3794-3","volume":"36","author":"Y Li","year":"2017","unstructured":"\u2022\u2022 Li Y, Zhou Y, Wang Q. Multiple values of (18)F-FDG PET\/CT in idiopathic inflammatory myopathy. Clin Rheumatol. 2017;36:2297\u2013305 This study demonstrates the multiple values of PET\/TC in patients with myositis by detecting malignancies, assessing muscle activity, determining interstitial lung activity, and predicting rapidly-progressive interstitial lung disease.","journal-title":"Clin Rheumatol"},{"key":"864_CR35","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1378\/chest.117.4.1173","volume":"117","author":"M Gaeta","year":"2000","unstructured":"Gaeta M, Blandino A, Scribano E, Minutoli F, Barone M, And\u00f2 F, et al. Chronic infiltrative lung diseases: value of gadolinium-enhanced MRI in the evaluation of disease activity--early report. Chest. 2000;117:1173\u20138.","journal-title":"Chest."},{"key":"864_CR36","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ejrad.2006.09.005","volume":"61","author":"G Lutterbey","year":"2007","unstructured":"Lutterbey G, Groh\u00e9 C, Gieseke J, von Falkenhausen M, Morakkabati N, Wattjes MP, et al. Initial experience with lung-MRI at 3.0T: comparison with CT and clinical data in the evaluation of interstitial lung disease activity. Eur J Radiol. 2007;61:256\u201361.","journal-title":"Eur J Radiol"},{"key":"864_CR37","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/joim.12480","volume":"280","author":"D Hilton-Jones","year":"2016","unstructured":"Hilton-Jones D, Brady S. Diagnostic criteria for inclusion body myositis. J Intern Med. 2016;280:52\u201362.","journal-title":"J Intern Med"},{"key":"864_CR38","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ana.23822","volume":"73","author":"H Pluk","year":"2013","unstructured":"Pluk H, van Hoeve BJ, van Dooren SH, Stammen-Vogelzangs J, van der Heijden A, Schelhaas HJ, et al. Autoantibodies to cytosolic 5\u2032-nucleotidase 1A in inclusion body myositis. Ann Neurol. 2013;73:397\u2013407.","journal-title":"Ann Neurol"},{"key":"864_CR39","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/acr.22600","volume":"68","author":"TE Lloyd","year":"2016","unstructured":"Lloyd TE, Christopher-Stine L, Pinal-Fernandez I, Tiniakou E, Petri M, Baer A, et al. Cytosolic 5\u2032-nucleotidase 1A as a target of circulating autoantibodies in autoimmune diseases. Arthritis Care Res (Hoboken). 2016;68:66\u201371.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"864_CR40","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ana.410390122","volume":"39","author":"JN Pruitt 2nd","year":"1996","unstructured":"Pruitt JN 2nd, Showalter CJ, Engel AG. Sporadic inclusion body myositis: counts of different types of abnormal fibers. Ann Neurol. 1996;39:139\u201343.","journal-title":"Ann Neurol"},{"issue":"5","key":"864_CR41","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1136\/annrheumdis-2018-214644","volume":"78","author":"James B Lilleker","year":"2019","unstructured":"\u2022\u2022 Lilleker JB, Hodgson R, Roberts M, Herholz K, Howard J, Hinz R, et al. [18F] Florbetapir positron emission tomography: identification of muscle amyloid in inclusion body myositis and differentiation from polymyositis. Ann Rheum Dis. 2019 Feb 13. https:\/\/doi.org\/10.1136\/annrheumdis-2018-214644 [18F] florbetapir positron emission tomography can detect tissue deposits of amyloid. In this study the authors suggest that this technique may allow to differentiate inclusion body myositis from polymyositis.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"864_CR42","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41584-019-0223-9","volume":"15","author":"I Pinal-Fernandez","year":"2019","unstructured":"Pinal-Fernandez I, Mammen AL. Amyloid-PET: a new tool for diagnosing IBM? Nat Rev Rheumatol. 2019;15:321\u20132.","journal-title":"Nat Rev Rheumatol"},{"key":"864_CR43","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/RLU.0000000000001218","volume":"41","author":"O Bennett","year":"2016","unstructured":"Bennett O, Ravi Kumar AS, Agnew J. Focal inflammatory myositis on 18F-FDG PET\/CT. Clin Nucl Med. 2016;41:469\u201371.","journal-title":"Clin Nucl Med"},{"key":"864_CR44","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/RLU.0000000000002427","volume":"44","author":"A Dong","year":"2019","unstructured":"Dong A, Bai Y, Wang Y. Focal myositis of the leg presenting as fever of unknown origin detected by FDG PET\/CT. Clin Nucl Med. 2019;44:251\u20134.","journal-title":"Clin Nucl Med"},{"key":"864_CR45","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/art.38622","volume":"66","author":"I Marie","year":"2014","unstructured":"Marie I, Sauv\u00eatre G, Becker S, Bedat-Millet AL. Clinical images: focal myositis demonstrated on positron emission tomography. Arthritis Rheumatol. 2014;66:1871.","journal-title":"Arthritis Rheumatol"},{"key":"864_CR46","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/clc.21964","volume":"35","author":"L Zhang","year":"2012","unstructured":"Zhang L, Wang GC, Ma L, Zu N. Cardiac involvement in adult polymyositis or dermatomyositis: a systematic review. Clin Cardiol. 2012;35:686\u201391.","journal-title":"Clin Cardiol"},{"key":"864_CR47","doi-asserted-by":"crossref","first-page":"e798","DOI":"10.1097\/MD.0000000000000798","volume":"94","author":"C Dieval","year":"2015","unstructured":"Dieval C, Deligny C, Meyer A, Cluzel P, Champtiaux N, Lefevre G, et al. Myocarditis in patients with antisynthetase syndrome: prevalence, presentation, and outcomes. Medicine (Baltimore). 2015;94:e798.","journal-title":"Medicine (Baltimore)"},{"key":"864_CR48","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.nmd.2018.11.012","volume":"29","author":"A Puwanant","year":"2019","unstructured":"Puwanant A, Isfort M, Lacomis D, \u017divkovi\u0107 SA. Clinical spectrum of neuromuscular complications after immune checkpoint inhibition. Neuromuscul Disord. 2019;29:127\u201333.","journal-title":"Neuromuscul Disord"},{"key":"864_CR49","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1253\/circj.CJ-16-0811","volume":"81","author":"T Shigematsu","year":"2016","unstructured":"Shigematsu T, Okayama H, Hiasa G, Kazatani Y. (18) F-fluorodeoxyglucose positron emission tomography for the diagnosis of myocarditis associated with polymyositis. Circ J. 2016;81:121\u20132.","journal-title":"Circ J"},{"key":"864_CR50","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.tcm.2018.08.004","volume":"29","author":"M Pelletier-Galarneau","year":"2019","unstructured":"Pelletier-Galarneau M, Ruddy TD. Molecular imaging of coronary inflammation. Trends Cardiovasc Med. 2019;29:191\u20137.","journal-title":"Trends Cardiovasc Med"},{"key":"864_CR51","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2967\/jnumed.114.150318","volume":"56","author":"HF Wehrl","year":"2015","unstructured":"Wehrl HF, Sauter AW, Divine MR, Pichler BJ. Combined PET\/MR: a technology becomes mature. J Nucl Med. 2015;56:165\u20138.","journal-title":"J Nucl Med"},{"key":"864_CR52","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejrad.2013.05.028","volume":"83","author":"H Jadvar","year":"2014","unstructured":"Jadvar H, Colleti PM. Competitive advantage of PET\/MRI. Eur J Radiol. 2014;83:84\u201394.","journal-title":"Eur J Radiol"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-019-0864-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-019-0864-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-019-0864-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T03:53:57Z","timestamp":1605844437000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-019-0864-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":52,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["864"],"URL":"https:\/\/doi.org\/10.1007\/s11926-019-0864-3","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"21 November 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"64"}}